Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veru Inc (NQ: VERU )

0.8059 -0.0241 (-2.90%)
Streaming Delayed Price Updated: 10:14 AM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Veru Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Veru Earnings Perspective: Return On Capital Employed
Via Benzinga
If You Invested $1,000 in Veru in 2020, This Is How Much You Would Have Today
Despite the recent sell-off, you'd still have a solid profit on Veru if you bought the stock nearly three years ago. 
Via The Motley Fool
$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Is There any Hope for Veru Stock?
The near term looks bad, and it might take a while to get better. 
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $5,600 Today
Via Benzinga
What's Going On With Veru Stock Today?
Veru Inc (NASDAQ: VERU) shares are trading higher Monday after the company reported fourth-quarter financial results. 
Via Benzinga
Earnings Scheduled For December 5, 2022
Companies Reporting Before The Bell • DLH Hldgs (NASDAQ:DLHC) is likely to report quarterly earnings at $0.25 per share on revenue of $67.00 million. 
Via Benzinga
Is Veru a Buy?
Or is it just another risky COVID stock? 
Via The Motley Fool
Veru Q4 2022 Earnings Conference Call On December 5, 2022 At 08:00 AM ET
Via Benzinga
Is It Too Late to Buy Veru Stock?
The negative impact of its COVID-19 program faltering will soon be in the past. 
Via The Motley Fool
Why Shares of Veru Fell 10.33% on Monday
Investors are concerned that approval for a COVID-19 therapy will be delayed or denied. 
Via The Motley Fool
$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Veru Stock Was Losing One-Third of Its Value This Week
The future of a top pipeline drug now looks much dimmer. 
Via The Motley Fool
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher
U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday. 
Via Benzinga
Oracle Layoffs 2022: What to Know About ORCL Job Cuts, Hiring Freeze
Oracle (ORCL) layoffs are worth checking out on Thursday as investors keep track of tech companies that are cutting employees. 
Via InvestorPlace
Dow Soars Over 900 Points; Nasdaq Over 600
Inflation data for October is sending stocks to the moon today. 
Via Talk Markets
Nasdaq Surges 600 Points; Gold Gains 2%
U.S. stocks traded sharply higher midway through trading , with the Nasdaq Composite gaining 600 points on Thursday. 
Via Benzinga
Why Is VERU Stock Down 50% Today?
The regulatory hammer is hitting VERU stock investors hard today as the FDA denies a crucial authorization for Veru's Covid-19 drug. 
Via InvestorPlace
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Veru Stock Is Cratering Today
A negative vote on one of its drugs is weighing on the biotech's stock price. 
Via The Motley Fool
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's... 
Via Benzinga
Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Dow Jumps Over 700 Points; US Inflation Rate Falls In October
U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday. 
Via Benzinga
Veru Stock Plummets 65% After FDA Advisors Vote Down Cancer-Turned-Covid Drug
The FDA isn't bound by the advisors' recommendation. But it does consider their vote. 
Via Investor's Business Daily
How Is The Market Feeling About Veru?
Veru's (NASDAQ:VERU) short percent of float has fallen 12.12% since its last report. The company recently reported that it has 14.69 million shares sold short, which is 22.76% of all regular shares... 
Via Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
Veru Inc. 
Via Benzinga
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug
While the FDA may have some questions regarding Veru’s Covid-19 therapeutic, investors remain optimistic about VERU stock. 
Via InvestorPlace
Dow Surges 400 Points; Crude Oil Down 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.